Ect2 and MgcRacGAP Regulate the Activation and Function of Cdc42 in Mitosis
Overview
Authors
Affiliations
Although Rho regulates cytokinesis, little was known about the functions in mitosis of Cdc42 and Rac. We recently suggested that Cdc42 works in metaphase by regulating bi-orient attachment of spindle microtubules to kinetochores. We now confirm the role of Cdc42 by RNA interference and identify the mechanisms for activation and down-regulation of Cdc42. Using a pull-down assay, we found that the level of GTP-Cdc42 elevates in metaphase, whereas the level of GTP-Rac does not change significantly in mitosis. Overexpression of dominant-negative mutants of Ect2 and MgcRacGAP, a Rho GTPase guanine nucleotide exchange factor and GTPase activating protein, respectively, or depletion of Ect2 by RNA interference suppresses this change of GTP-Cdc42 in mitosis. Depletion of Ect2 also impairs microtubule attachment to kinetochores and causes prometaphase delay and abnormal chromosomal segregation, as does depletion of Cdc42 or expression of the Ect2 and MgcRacGAP mutants. These results suggest that Ect2 and MgcRacGAP regulate the activation and function of Cdc42 in mitosis.
ECT2 promotes the occurrence and is a prognostic biomarker of head and neck squamous cell carcinoma.
Peng S, Wang J, Hei N, Cui Z J Cancer. 2024; 15(13):4156-4174.
PMID: 38947403 PMC: 11212090. DOI: 10.7150/jca.95515.
Transcriptome analysis of reproductive tract tissues of male river prawn Macrobrachium americanum.
Martin-Manzo M, Morelos-Castro R, Munguia-Vega A, Soberanes-Yepiz M, Cortes-Jacinto E Mol Biol Rep. 2024; 51(1):259.
PMID: 38302799 DOI: 10.1007/s11033-023-09125-6.
Sosnovski K, Braun T, Amir A, BenShoshan M, Abbas-Egbariya H, Ben-Yishay R Sci Rep. 2023; 13(1):20513.
PMID: 37993670 PMC: 10665440. DOI: 10.1038/s41598-023-47997-7.
Identification of a small RhoA GTPase inhibitor effective in fission yeast and human cells.
Morishita J, Nurse P Open Biol. 2023; 13(3):220185.
PMID: 36854376 PMC: 9974304. DOI: 10.1098/rsob.220185.
Increased expression of ECT2 predicts the poor prognosis of breast cancer patients.
Yi M, Zhang D, Song B, Zhao B, Niu M, Wu Y Exp Hematol Oncol. 2022; 11(1):107.
PMID: 36572949 PMC: 9791744. DOI: 10.1186/s40164-022-00361-3.